Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.530
+0.017 (3.37%)
At close: Jan 17, 2025, 4:00 PM
0.515
-0.015 (-2.81%)
After-hours: Jan 17, 2025, 7:37 PM EST
Onconetix Employees
Onconetix had 12 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$155,884
Profits / Employee
-$4,300,296
Market Cap
4.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12 | 0 | - |
| Dec 31, 2022 | 12 | 7 | 140.00% |
| Dec 31, 2021 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ONCO News
- 5 weeks ago - Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing - GlobeNewsWire
- 3 months ago - Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board - Business Wire
- 3 months ago - Correction: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewsWire
- 3 months ago - Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit - GlobeNewsWire
- 4 months ago - Crude Oil Rises; Onconetix Shares Spike Higher - Benzinga
- 4 months ago - Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders - GlobeNewsWire
- 6 months ago - Onconetix Announces Closing of Warrant Exercise for $1.11 Million Gross Proceeds - GlobeNewsWire
- 6 months ago - Onconetix Announces Exercise of Warrants for $1.11 Million Gross Proceeds - GlobeNewsWire